CDC CONSULTANCY
CDC CONSULTANCY has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €318k and a net result of €190k. Equity is shrinking by ~18.2% per year across the filed fiscal years. Its solvency ranks better than 59% of 4760 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
| Equity | €318k |
| Net result | €190k |
| Better than sector | 59% |
| Active | 7 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 66.0% | 55.4% | |
| Net result | €190k | €38k | |
| Equity | €318k | €64k | |
| Gross operating margin | €243k | €61k | |
| Total assets | €482k | €146k |
Figures by fiscal year and ratios
| Fiscal year | 2025 Δ | 2024 Δ | 2023 Δ |
|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema |
| Revenue | - | - | - |
| EBITDA | +93.6% | -62.5% | - |
| Net profit | +104.1% | -63.2% | - |
| Cash flow | +93.8% | -61.2% | - |
| Staff costs | - | - | - |
| Income taxes | +124.0% | -66.4% | - |
| Dividends | - | - | - |
| Total assets | -21.3% | +16.8% | - |
| Equity | -46.4% | +18.5% | - |
| Debt | +799.4% | -21.3% | - |
| of which ≤ 1y | +799.4% | -21.3% | - |
| of which > 1y | - | - | - |
| Working capital | -47.7% | +21.3% | - |
| Employees (FTE) | - | - | - |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current ratio | 2.82 | 32.27 | 21.30 |
| Quick ratio | 2.82 | 32.27 | 21.30 |
| Working capital ratio | 61.8% | 93.0% | 89.6% |
| Solvency | 66.0% | 97.0% | 95.6% |
| Debt / equity | 0.51 | 0.03 | 0.05 |
| Long-term debt ratio | - | - | - |
| Interest coverage | 4395.64 | 2270.03 | 6664.74 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | 39.3% | 15.2% | 48.1% |
| ROE | 59.6% | 15.6% | 50.4% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Full annual accounts (22 line items)
| Line item | Code | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €482k | €612k | €524k |
| Fixed assets | 21/28 | €20k | €24k | €31k |
| Tangible fixed assets | 22/27 | €20k | €24k | €31k |
| Current assets | 29/58 | €461k | €587k | €492k |
| Amounts receivable within one year | 40/41 | €127k | €24k | €78k |
| Investments | 50/53 | €56k | €207k | €176k |
| Cash & bank | 54/58 | €124k | €354k | €236k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €482k | €612k | €524k |
| Equity | 10/15 | €318k | €594k | €501k |
| Contributions / capital | 10/11 | €500 | €500 | €500 |
| Reserves | 13 | €318k | €593k | €500k |
| Amounts payable | 17/49 | €164k | €18k | €23k |
| Amounts payable within one year | 42/48 | €164k | €18k | €23k |
| Trade debts payable within one year | 44 | €5k | €7k | €7k |
| Income statement | ||||
| Gross operating margin | 9900 | €243k | €126k | €334k |
| Operating result | 9901 | €238k | €118k | €328k |
| Financial income | 75 | €10k | €926 | €1k |
| Financial charges | 65 | €55 | €55 | €50 |
| Result before taxes | 9903 | €247k | €119k | €329k |
| Income taxes | 67/77 | €58k | €26k | €77k |
| Net result for the period | 9904 | €190k | €93k | €252k |
| Result to be appropriated | 9905 | €190k | €93k | €252k |
| NACE primary | Business and other management consultancy(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 13-08-2019 |
| Status | Active |
| Postal code | 9031 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44017A0846/00A003 | Flanders | 892 m² | 1 · 144 m² | 8.4 m · 2 fl. |
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | CDC CONSULTANCY |